Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.5.1.22NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.2.75NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.5 (Omicron)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.5.5NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
CH.1.1.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.4.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-19212.8Germany
BA.5.2.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.5.2.3NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.2.36NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BE.1.1.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BN.1.5NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BF.7NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.2.23NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.5.2.44NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BN.1.3.9NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
JN.1.49.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
JN.3.2.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
LB.1.6NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
JN.3.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
GE.1.2.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
JN.1.58.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
JN.1.8.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
KP.1.1.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
JN.1.4.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XDD.1.1.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XDNNCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
LH.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
HW.1.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
JN.1.55.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
JN.1.18.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-18735.2Germany
XDK.4.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
KP.3.4.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
KP.2.11NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
LS.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.1.1 (Omicron)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.5.2.14NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.4 (Omicron)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-19212.8Germany
DN.3NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
HK.3.7NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.4.1.3NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-19212.8Germany
BW.1.1.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XBB.2.7NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.312NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
FL.13.4NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.220NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.142NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.523NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
FW.1.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
HN.3.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.1.1.17NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used